Skip to main content
Log in

GLP-1-Agonisten kombiniert mit Basalinsulin in der Behandlung des Diabetes mellitus Typ 2

GLP-1 agonists combined with basal insulin in the treatment of type 2 diabetes mellitus

  • Journal Club
  • Published:
Der Diabetologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Interessenkonflikt

V. Pavlicek nimmt am Advisory Board für Novo-Nordisk und Lilly teil.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. Pavlicek.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pavlicek, V. GLP-1-Agonisten kombiniert mit Basalinsulin in der Behandlung des Diabetes mellitus Typ 2. Diabetologe 10, 662–664 (2014). https://doi.org/10.1007/s11428-014-1317-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11428-014-1317-2

Navigation